Palmerston North Hospital · July 3, 2026

How Low Can You Go

Platelets, Penguins & Ghost Policies

An evidence-based recalibration of procedural platelet count thresholds

Roman Vasilev · Specialist Anaesthetist 01
The case that started it all
G2P1, 32 years old, admitted next week for delivery. Big baby — would benefit from epidural. Platelet count 78,000. Anaesthetist reviewed — requests platelet count above 80,000 before proceeding.

No verdict yet. Just the facts as they were presented.

Case vignette — gestational thrombocytopenia 02
The case that started it all
G2P1, 32 years old, admitted next week for delivery. Big baby — would benefit from epidural. Platelet count 78,000. Anaesthetist reviewed — requests platelet count above 80,000 before proceeding.

No verdict yet. Just the facts as they were presented.

QR code — scan to join the quiz

Scan to join the quiz

Interactive quiz — scan to participate 03

Results

Quiz results & answer key 04
Problem

Ghost Policies: What Are They?

An unwritten, arbitrary platelet count threshold — passed down by word-of-mouth, found in no published guideline, enforced as if it were institutional policy.

Example: “Plt < 80K? No epidural.”

  • Never written down in any departmental protocol
  • Never evidence-based — no RCT supports it
  • Contradicted by SOAP 2021, ANZ ITP 2022, AAGBI 2013
  • Yet it determines whether a patient receives neuraxial anaesthesia
Ghost policies are not benign. They override evidence-based guidelines with institutional habit — and patients pay the price.
"I was trained to do it like this"
Trainer → trainee hand-me-down
"We've always done it this way"
Department culture, never questioned
"Someone told me it was the rule"
Oral tradition with no written source
Ghost policies — unwritten, un-evidenced, unchallenged 05

What other ghost policies do you know?

Pause for discussion 06

Well-Recognised Ghost Policies
in Anaesthesiology

  • “Nil by mouth after midnight”
    Rigid 6–8 h fasting — despite clear fluids clearing the stomach in <2 h (ASA 2017/2023; ESA-IC 2022)
  • “Hold all regular meds — patient is NPO
    ASA 2012: essential meds should continue with sips of water. β-blocker withdrawal → 2–4× perioperative MI risk
  • “Cricoid pressure prevents aspiration”
    Sellick 1961 (n=26), never proven in an RCT. NAP4: aspiration in 50% of airway deaths regardless. Birenbaum 2019 RCT: no difference
  • “Preload with crystalloid before spinal”
    Ni 2017 meta-analysis (10 RCTs, n=824): preload 57.8% hypotension vs coload 47.1% (OR 1.62). Vasopressors are what matter
  • “Trendelenburg for hypotension”
    Geerts 2012: increases preload for ≤1 min — baroreceptor resetting eliminates the effect. Leg raise more effective, plus no ventilation impairment or ICP rise
  • “Aspirin = no neuraxial”
    ASRA 2025: NSAIDs “do not create a level of risk that will interfere with neuraxial block.” Confusion with P2Y12 inhibitors (clopidogrel) which DO require 5–7 day hold
  • “Routine coagulation screen before neuraxial”
    ASA guidelines: history & exam sufficient. van Veen 2010: routine PT/APTT has near-zero predictive value. Chee 2008: “not recommended”
  • “Spinal contraindicated in severe aortic stenosis”
    Titrated epidural or low-dose spinal may be safer than GA — individualised risk assessment, not an absolute
  • “No adrenaline in digital blocks”
    Ilicki 2015: 2,797 blocks, zero ischaemic complications. The 48 pre-1950 cases were procaine (pH ~1), not adrenaline. 1,111 modern cases — zero necrosis
  • “Ketamine contraindicated in raised ICP
    Zeiler 2018 systematic review: no ICP elevation in TBI. 1970s studies had uncontrolled CO₂ — ICP rise was CO₂-mediated
  • “No Hartmann's in renal failure — the potassium will cause hyperkalaemia”
    Contains only 5 mmol/L K+ — less than a banana. SMART secondary analysis 2021: patients WITH hyperkalemia had less progression to severe K+ and half the need for RRT with balanced crystalloids vs saline. The “safe” saline makes it worse (hyperchloremic acidosis → transcellular K+ shift)
How many of these have you heard in theatre this month? 07
Origins

How Ghost was born

BCSH 2017Guidelines for the use of platelet transfusionsBr J Haematol 2017;176:365–394
NICE NG24 2015Blood Transfusion (Rec. 1.7.4–1.7.7)Critical sites (CNS, spine, eye): >100×10⁹/L
MisappliedNeither mentions neuraxial anaesthesia
Plt < 100K"No epidural" — zero guideline basis
Rasmus 1989Unrecognized thrombocytopenia and regional anesthesiaObstet Gynecol 1989 (n=10)
Beilin 1997Safe epidural analgesia with Plt 69–98KAnesth Analg 1997 (n=30)
van Veen 2010Spinal haematoma risk in thrombocytopenic individualsBr J Haematol 2010 (PMID: 19775301)
Became absolute cutoffAuthors warned: expert opinion only
Plt < 80K"No spinal" — contradicted by SOAP, AAGBI, ANZ ITP
NICE NG24 2015Blood Transfusion (Rec. 1.7.4–1.7.7)Invasive procedures: maintain >50×10⁹/L
BCSH 2017Guidelines for the use of platelet transfusionsBr J Haematol 2017 — LP>40K, CVC>20K
Transfusion trigger"Consider transfusion" ≠ "Do not proceed"
Plt < 50K"No procedures" — misapplied transfusion target
Cochrane 2016/2018: Zero RCTs support ANY threshold
"I was trained to do it like this"
Trainer → trainee hand-me-down
"We've always done it this way"
Department culture, never questioned
"Someone told me it was the rule"
Oral tradition with no written source
Three ghost policies — none supported by a single RCT 08
Why this matters

The Cost of Ghost Policies

Clinical Harm

  • Denying neuraxial → more general anaesthetics
  • GA in obstetrics: significant morbidity and mortality
  • Unnecessary platelet transfusions → TRALI, TACO, alloimmunization
  • Delays, prolonged admissions, wasted blood products

NZ Medicolegal Risk

  • HDC Right 4(2): services must comply with professional standards → MCNZ requires evidence-based practice
  • Right 6: patients entitled to know guidelines support proceeding at ≥70K
  • Bolitho: practice contradicted by all published guidelines cannot withstand logical scrutiny
  • “You must always be prepared to explain your decisions” — MCNZ Good Medical Practice
Clinical harm + medicolegal exposure 09
Evidence

What Guidelines Actually Say

GuidelineRecommendationReference
SOAP 2021 ≥70K → Proceed  |  50–70K → Competing risks may justify  |  <50K → Avoid SOAP 2021 Interdisciplinary Consensus Statement on Neuraxial Procedures in Obstetric Patients with Thrombocytopenia. Anesth Analg 2021;132:1531–1544. PMID: 33861047
AAGBI / RA-UK 2013 ITP/Gestational: 50–75K increased risk, 20–50K high risk  |  Pre-eclampsia: <75K very high risk (if abnormal coags) Harrop-Griffiths W, et al. Regional anaesthesia and patients with abnormalities of coagulation. Anaesthesia 2013;68:966–972. PMID: 23905877
ANZ ITP 2022 ≥70 × 10⁹/L is reasonable for neuraxial (GRADE 2D) Choi PY-I, et al. Australian and New Zealand consensus statement on the management of immune thrombocytopenia in pregnancy. Med J Aust 2022;217:43–51. PMID: 34628650
Bauer Meta-analysis 2019 Inflection point at 75K — below this, risk increases (19,000+ procedures) Bauer ME, et al. Lumbar neuraxial procedures in thrombocytopenic patients: systematic review and meta-analysis. J Clin Anesth 2019;57:103–110. PMID: 31810860
MPOG 2017 573 neuraxial with Plt <100K — zero epidural haematomas Lee LO, et al. Risk of Epidural Hematoma after Neuraxial Techniques in Thrombocytopenic Parturients. Anesthesiology 2017;126:1053–1063. PMID: 28383323
Key message: ≥70–75,000/μL is the consensus threshold across all major guidelines. SOAP 2021 was the inflection point — the evidence shifted. Our practice hasn't caught up.
Guidelines consensus — ≥70K is the evidence-based threshold 10
Statistical reasoning

Zero Observations ≠ Zero Risk

A cute blue penguin in front of Palmerston North Hospital Emergency Department
Observing zero events is not the same as zero risk 11
Statistical reasoning

Interpreting “Zero”: The Rule of Three

What are the chances of seeing a penguin on the way to work? Zero. But does that mean the probability is exactly zero? Of course not — a zoo escapee is astronomically unlikely, but not impossible. Observing zero events is not the same as zero risk. This is the statistical problem at the heart of every platelet threshold guideline.

The Rule of Three

  • Hanley & Lippman-Hand, JAMA 1983 — a landmark paper addressing exactly this problem
  • Calculates the maximum possible risk with 95% confidence when zero events are observed
  • Formula: Maximum Risk ≈ 3 / n (where n = sample size)

“If you flip a coin 3 times and get zero heads, you'd have no confidence the coin was fair. But flip it 300 times and still get zero heads — you're confident the probability of heads is less than about 1%.”

No penguins in 300 commutes → you're confident the daily penguin probability is under ~1%. Same logic, different stakes.

Applying It to the Obstetric Data

Lee et al. (2017): 0 SEH in 1,524 neuraxial procedures with Plt <100K

  • Maximum Risk ≈ 3 / 1,524
  • Maximum Risk ≈ 0.00197
  • Maximum Risk ≈ 0.2% (or 1 in 500)

We can be 95% confident that the true risk of spinal epidural haematoma in thrombocytopenic parturients, at the platelet counts studied, is no higher than 0.2% — roughly 1 in 500.

This turns an uncertain “zero” into a confident, quantifiable risk ceiling that can be weighed against the known risks of general anaesthesia.

Source: Hanley JA, Lippman-Hand A. If Nothing Goes Wrong, Is Everything All Right? Interpreting Zero Numerators. JAMA 1983;249:1743–1745.

Rule of Three — ≤0.2% maximum SEH risk (95% CI) 12
Caveats

Rule of Three: Limitations & Why We Still Use It

Critical Limitations

  1. It's an approximation. The “3” is a convenient rounding of −ln(0.05) = 2.9957
  2. Assumes perfect data. Doesn't account for selection bias (academic centres only) or publication bias (zero-event studies less likely published)
  3. Ignores prior knowledge. A Bayesian approach would start with our existing belief that SEH is rare — the true estimated risk would be even lower

Why We Still Use It

  1. Simple and universal. All major papers in this field use it — creates a common language for discussing risk
  2. Usefully conservative. The critiques suggest the true risk is likely even lower than 0.2%
  3. Clinically actionable. ≤0.2% max SEH risk (≤1:500) puts a concrete ceiling on what was an unknown. GA carries its own real risks (failed intubation 1:224–1:808). Both matter — ghost policies ignore both sides of the ledger.

By using the 0.2% figure, we are presenting a conservative, worst-case scenario that is still incredibly reassuring compared to the alternatives.

Critique informed by: Winkler RL, et al. J Am Stat Assoc 2002. Bayesian perspective: Gelman A, et al. Bayesian Data Analysis 3rd ed. 2013, Chapter 2.8.

Rule of Three — conservative, universal, clinically actionable 13
Risk comparison

The Hidden Risk: GA vs Neuraxial

General Anaesthesia (Obstetric)

1:224–1:808

Failed tracheal intubation in obstetric GA (range: Quinn BJA 2013 → DREAMY 2021)

Of those failed intubations, case fatality rate:

1:90

Maternal deaths per failed intubation (Kinsella, IJOA 2015)

Absolute risk of maternal death from GA (airway):

≈1:20,000–1:72,000

= failed intubation rate × case fatality rate

  • Aspiration: full stomach in labour
  • Hypertensive response to laryngoscopy
  • Uterine atony from volatile agents
  • No neuraxial opioids for post-op analgesia

Spinal Epidural Haematoma

~1:200,000

General obstetric population (Moen, Anesthesiology 2004; NAP3, 2009)

Zero cases

In 573 neuraxials with Plt <100K (MPOG 2017)

Mitigations:

  • 95% of SEH present symptoms within 48h
  • Early decompressive laminectomy (<8h) is critical
  • Enhanced neurological monitoring detects signs
  • Low-concentration LA + opioid preserves motor function
Remember our 78K case? The case fatality rate of a failed obstetric GA intubation is 1:90 — but the failed intubation rate itself is 1:224–1:808 (absolute airway death risk ≈1:20,000–72,000). Against that, the maximum SEH risk at Plt 78K is ≤0.2% (≤1:500). Neither risk is zero — the point is both are quantifiable, and a blanket 80K threshold ignores this balance. Individualised decision-making, not a ghost policy, should guide the choice.
GA risk vs SEH risk — both sides of the ledger matter 14
Clinical reasoning

Why Platelet Count Can Mislead

  • Platelet count measures quantity, NOT function
  • ITP / gestational: low count but young, large, hyperfunctional platelets — count underestimates haemostatic capacity
  • Cirrhosis / liver disease: normal count may mask severe platelet dysfunction
  • CKD / uraemia: normal count + dysfunctional platelets
  • No correlation between platelet count and surgical bleeding (Slichter, Transfus Med Rev 2004)
  • Bleeding time: abandoned — no predictive value (Lind, Blood 1991)
Count ≠ function. The same number means different things depending on aetiology.
Platelet count — quantity, not function 15
Beyond the count

TEG / ROTEM: Looking Beyond the Count

Viscoelastic Testing

  • TEG MA predicts thrombocytopenia: AUC 0.92 (Bhardwaj 2017)
  • Sonoclot PF correlates with platelet count: r = 0.85
  • ROTEM INTEM MCF correlates with count: r = 0.46
  • High negative predictive value for post-op bleeding

Clinical Role

  • SOAP 2021: insufficient evidence for routine use — consider in equivocal cases
  • PFA-100: insufficient evidence (SOAP, AAGBI)
  • Best used when count is borderline and aetiology uncertain
  • Normal TEG/ROTEM is reassuring; abnormal should prompt caution
TEG/ROTEM — viscoelastic testing for borderline cases 16
Clinical approach

Workup for the Low Platelet Count Patient

History & Exam

  • Bleeding history (epistaxis, gingival, menorrhagia, bruising)
  • Medications (heparin, NSAIDs, aspirin, anticonvulsants)
  • Previous platelet counts — acute vs chronic?
  • Hepatosplenomegaly, lymphadenopathy, petechiae
  • Pregnancy: pre-eclampsia features, BP, urinalysis

Laboratory Workup

  • FBC + blood film (pseudothrombocytopenia? schistocytes?)
  • Coagulation screen (PT, aPTT, fibrinogen)
  • Liver function tests, creatinine
  • TEG/ROTEM — if available and count borderline

Pattern Recognition

AetiologyCountFunctionBleeding Risk
GestationalNormal/↑Low
ITP↓↓Normal/↑Variable
Pre-eclampsia/HELLPHigh
Liver diseaseVariable↓↓High
DIC↓↓↓↓Very high

Decision Framework

  • ≥70K + no coagulopathy + reassuring history → proceed
  • 50–70K + ITP/gestational → risk-benefit discussion
  • <50K or concerning aetiology → consult haematology
Workup — history, labs, pattern recognition, decision 17

The Aetiology Matters More
Than the Count

ITP · Pre-eclampsia · Cirrhosis · Sepsis

18
Local context

NZ & Australian Guidelines

ANZCA

  • Endorses NBA Patient Blood Management Guidelines (2023–24)
  • NBA Module 2: Perioperative (ANZCA endorsed)
  • NBA Module 5: Obstetrics (ANZCA endorsed)
  • No standalone ANZCA platelet threshold guideline exists
  • References AAGBI/RA-UK 2013 in practice
  • ANZCA PS08: safety-focused

ANZ ITP Consensus 2022

  • ≥70 × 10⁹/L is reasonable for neuraxial anaesthesia
  • GRADE 2D (weak recommendation, low quality evidence)
  • Published in MJA — official ANZ haematology position
  • Consider haematology referral for counts <50K
  • IVIg or corticosteroids can boost pre-delivery counts
  • “Individual risk-benefit assessment is essential”

NZ Blood Service

  • NZBS follows ANZSBT guidance
  • Not procedure-specific thresholds
  • Prophylactic: Plt <10K (no bleeding) or <20K (with risk factors)
  • Therapeutic: active bleeding + Plt <50K
  • One adult dose: raises Plt by ~30–50 × 10⁹/L
  • ABO-identical preferred when available

ANZCA has no independent platelet threshold guideline — it endorses NBA and ANZ ITP consensus. AAGBI 2013 and SOAP 2021 are the most clinically useful references.

NZ & AU — ANZCA, ANZ ITP, NZBS 19
Action

Practical Decision Algorithm for Neuraxial

① Assess Aetiology

ITP / Gestational?
(vs pre-eclampsia, DIC, sepsis, liver disease)

Aetiology determines true bleeding risk

② Check Trend

Stable or rising? → more permissive

Falling rapidly? → more cautious

Trajectory matters more than absolute nadir

③ Platelet Count

≥70K → Proceed
(SOAP / AAGBI)

50–70K → Risk-benefit discussion

<50K → Avoid; consult haematology

④ Risk-Benefit Analysis

GA risk vs SEH risk. Difficult airway? Obesity? Labour? GA may be the RISKIER option. → Document reasoning.

⑤ Mitigations

Experienced operator. Low-concentration LA + opioid mix. Enhanced neuro monitoring × 48h. Educate patient re: red flags.

Adapted from: SOAP 2021, AAGBI 2013, Bauer et al. 2019. Always document risk-benefit discussion and monitoring plan.

5-step algorithm — aetiology, trend, count, risk-benefit, mitigations 20
Summary

Replace Ghost Policies With Evidence

#RecommendationRationale
1Individualised Risk-Benefit AssessmentReplace rigid thresholds with documented clinical judgement
2≥70K = Evidence-Based Green ZoneSOAP, AAGBI, ANZ ITP consensus all support neuraxial at ≥70K
3GA Is NOT the “Safe” DefaultFailed intubation 1:224–1:808; case fatality per failed attempt 1:90 — GA has real, quantifiable risks that should factor into the decision alongside SEH risk
4Platelet Count ≠ FunctionITP: low count, normal function. Pre-eclampsia: opposite. Aetiology matters
5Document & AuditRecord aetiology, trend, guidelines, risk-benefit. Audit neuraxial denial rates
6Mitigate Bleeding RiskUS-guided technique + experienced operator + atraumatic needle + low-concentration LA
✓ Ghost policies deny patients optimal care. ≥70K is the evidence-based consensus.

Our 78K patient? Gestational thrombocytopenia, no bleeding history, Plt 78K — well above the SOAP/AAGBI/ANZ ITP ≥70K threshold. The haematologist was right to proceed. Dexamethasone was unnecessary. ≤0.2% max SEH risk. Failed obstetric GA intubation 1:224–1:808. The only ghost policy in that consultation was the 80K rule.

If you see zero penguins in 1,524 commutes, you're ≤0.2% confident of seeing one tomorrow. Same data, same logic, applied to our patients.

Summary — case callback + penguin callback 21
Appendix

Procedure Thresholds at a Glance

Invasive Procedures

ProcedurePlt/μLSource
CVC (US-guided, IJ/SCV)20,000BCSH 2016; PACER: ≥30K for tunneled/haem
Lumbar Puncture40,000van Veen 2009; BCSH 2016
Arterial Line (radial)No specificSIR — compressible site
PICC Line20,000Similar to CVC; compressible
Intercostal Drain50,000NICE NG24
General / Abdominal Surgery50,000NICE NG24; 50–75K for high-risk
PACER Trial (NEJM 2023): US-guided CVC in Plt 10–50K: 11.9% grade 2–4 bleeding without transfusion vs 4.8% with. No grade 4 bleeding in either group. Net savings $410/catheter.

Peripheral Nerve Blocks

Risk TierPlt/μLExamples
● Low (superficial, compressible)≥50KFascia iliaca, femoral, axillary, popliteal, ankle/wrist
● Intermediate (deeper, partial)≥50–75KInterscalene, supraclavicular, infraclavicular, adductor canal
● High (deep, non-compressible)≥75K (treat as neuraxial)Lumbar plexus, deep cervical, stellate, coeliac

Sources: PACER — van Baarle et al. NEJM 2023. PNB — AAGBI/RA-UK 2013 Table 2; ASRA 5th Ed 2025. Invasive — BCSH 2016; NICE NG24; SIR 2019.

Appendix — invasive procedures + peripheral nerve blocks 22
Reference

References

[1] SOAP 2021 — Neuraxial procedures in thrombocytopenic obstetric patients. Anesth Analg. PMID 33861047

[2] AAGBI/RA-UK 2013 — Regional anaesthesia & coagulation abnormalities. Anaesthesia. PMID 23905877

[3] Bauer 2019 — Neuraxial procedures in thrombocytopenia: meta-analysis. J Clin Anesth. PMID 31810860

[4] van Veen 2010 — Spinal haematoma risk in thrombocytopenia. Br J Haematol. PMID 19775301

[5] Lee MPOG 2017 — Epidural hematoma in thrombocytopenic parturients. Anesthesiology. PMID 28383323

[6] van Baarle PACER 2023 — Platelet transfusion before CVC placement. NEJM. PMID 37224197

[7] Estcourt Cochrane 2016/2018 — No RCTs on platelet thresholds for neuraxial. PMID 29709077

[8] NICE NG24 2015 — Blood transfusion guideline. nice.org.uk/guidance/ng24

[9] BCSH 2017 — Guidelines for platelet transfusions. Br J Haematol. PMID 28009056

[10] ANZ ITP 2022 — Management of adult ITP in Australia & NZ. Med J Aust. PMID 34628650

[11] NBA PBM 2023–24 — Patient blood management guidelines. blood.gov.au

[12] NAP3 2009 — Major complications of neuraxial block in UK. Br J Anaesth. PMID 19139027

[13] Bhardwaj 2017 — Coagulopathies: TEG, ROTEM, Sonoclot analysis. Ann Card Anaesth. PMID 28393783

[14] Kinsella 2015 — Failed intubation in obstetric GA: review. Int J Obstet Anesth. PMID 26303751

[14a] Quinn 2013 — Failed intubation: UK case-control. Br J Anaesth. PMID 22986421

[14b] DREAMY 2021 — GA for obstetric surgery in England. Anaesthesia. PMID 32959372

[15] Moen 2004 — Neurological complications after neuraxial block. Anesthesiology. PMID 15448529

[16] SIR 2019 — Periprocedural bleeding risk management. J Vasc Interv Radiol. PMID 31229333

[17] Hanley 1983 — Rule of Three: interpreting zero numerators. JAMA. PMID 6827763

[18] Slichter 2004 — Platelet count & bleeding risk. Transfus Med Rev. PMID 15248165

[19] Lind 1991 — Bleeding time does not predict surgical bleeding. Blood. PMID 2043759

References — 19 cited sources 23
Reference

Abbreviation Key

Guidelines & Organisations

SOAP — Society for Obstetric Anesthesia and Perinatology

AAGBI — Association of Anaesthetists of GB & Ireland

ANZCA — Australian & NZ College of Anaesthetists

ANZ ITP — ANZ Immune Thrombocytopenia Consensus

BCSH — British Committee for Standards in Haematology

NICE — National Institute for Health and Care Excellence

NBA — National Blood Authority (Australia)

NZBS — New Zealand Blood Service

ANZSBT — ANZ Society of Blood Transfusion

SIR — Society of Interventional Radiology

MCNZ — Medical Council of New Zealand

HDC — Health and Disability Commissioner

Regulatory

HDC Code — NZ Code of Health and Disability Services Consumers' Rights

Bolitho — Bolitho v City and Hackney HA [1997] (logical basis test)

Databases & Trials

MPOG — Multicenter Perioperative Outcomes Group

PACER — Platelet Transfusion before CVC Placement trial

NAP3 — Third National Audit Project (RCoA)

DREAMY — GA for Obstetric Surgery in England study

Cochrane — Cochrane Database of Systematic Reviews

Clinical Terms

ITP — Immune Thrombocytopenia

SEH — Spinal Epidural Haematoma

GA — General Anaesthesia

TRALI — Transfusion-Related Acute Lung Injury

TACO — Transfusion-Associated Circulatory Overload

TEG — Thromboelastography

ROTEM — Rotational Thromboelastometry

PFA-100 — Platelet Function Analyzer-100

RCT — Randomised Controlled Trial

CVC — Central Venous Catheter

HELLP — Haemolysis, Elevated Liver enzymes, Low Platelets

DIC — Disseminated Intravascular Coagulation

Reference Key — abbreviations expanded 24

Thank You

Questions & Discussion

Roman Vasilev · Specialist Anaesthetist · Palmerston North Hospital

Prepared June 2026 — evidence current as of May 2026

25
← / → · space